Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799

This publication has 10 references indexed in Scilit:

• Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer
  Journal of Medicinal Chemistry, 2010
• Targeting the phosphoinositide 3-kinase pathway in cancer
  Nature Reviews Drug Discovery, 2009
• Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity
  Molecular Cancer Therapeutics, 2008
• Antitumor Activity of ZSTK474, a New Phosphatidylinositol 3-Kinase Inhibitor
  JNCI: Journal of the National Cancer Institute, 2006
• Oncogenic PI3K deregulates transcription and translation
  Nature Reviews Cancer, 2005
• Structural Determinants of Phosphoinositide 3-Kinase Inhibition by Wortmannin, LY294002, Quercetin, Myricetin, and Staurosporine
  Molecular Cell, 2000
• Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6
  British Journal of Cancer, 1999
• A Fast Flexible Docking Method using an Incremental Construction Algorithm
  Journal of Molecular Biology, 1996
• Placement of medium-sized molecular fragments into active sites of proteins
  Journal of Computer-Aided Molecular Design, 1996
• A convenient preparation of methyl 2,5-dihydro-2-oxo-3-furancarboxylate
  The Journal of Organic Chemistry, 1978